Literature DB >> 19801

Pharmacokinetics of N-desmethyldiazepam in healthy volunteers after single daily doses of dipotassium chlorazepate.

C Post, S Lindgren, A Bertler, H Malmgren.   

Abstract

Dipotassium chlorazepate was administered to 12 healthy volunteers (8 males and 4 females), aged 22-38 years, as a single daily dose of 20 mg for 14 days. Plasma concentrations of N-desmethyldiazepam were monitored with a gas-chromatographic method during the medication period and for 5 days after withdrawal of the drug. The plasma half-life (t1/2), the elimination coefficient (Kbeta), the concentration (Css), and the apparent volume of distribution (Vbeta) were calculated at steady state, and the mean values +/- SEM were 53 +/- 6 h, 0.0147 +/- 0.0013 h-1, 884 +/- 73 ng/ml, and 1.13 +/- 0.08 1/kg, respectively. A moderate interindividual variability was observed regarding these parameters. There was no tendency toward a biexponential elimination. A significant difference in the apparent volume of distribution was found when males and females were compared.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19801     DOI: 10.1007/BF00426477

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects.

Authors:  M Tansella; O Siciliani; L Burti; M Schiavon; C Zimmermann; M Gerna; G Tognoni; P L Morselli
Journal:  Psychopharmacologia       Date:  1975

2.  A simple method for determining diazepam and its major metabolites in biological fluids: application in bioavailability studies.

Authors:  E Arnold
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-04

3.  A rapid gas chromatographic method for the determination of diazepam and metabolites in body fluids.

Authors:  A G Howard; G Nickless; D M Hailey
Journal:  J Chromatogr       Date:  1974-04-10

4.  Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect.

Authors:  H H Dasberg; E van der Kleijn; J P Guelen; H M van Praag
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

5.  Diazepam metabolism during chronic medication unbound fraction in plasma, erythrocytes and urine.

Authors:  I A Zingales
Journal:  J Chromatogr       Date:  1973-01-03

6.  Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data.

Authors:  A Berlin; B Siwers; S Agurell; A Hiort; F Sjöqvist; S Ström
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

7.  Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline.

Authors:  G Tognoni; R Gomeni; D De Maio; G G Alberti; P Franciosi; G Scieghi
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

8.  Clinical and biochemical comparison of clorazepate and diazepam.

Authors:  A Robin; S H Curry; R Whelpton
Journal:  Psychol Med       Date:  1974-11       Impact factor: 7.723

9.  Oral diazepam in hospitaized anxiety patients (with observations on concentration-effect-relationships).

Authors:  H Dasberg
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1975-07

10.  Determination of medazepam (nobrium), diazepam(valium) and their major biotransformation products in blod and urine by electron capture s-liquid chromatography.

Authors:  J A De Silva; C V Puglisi
Journal:  Anal Chem       Date:  1970-12       Impact factor: 6.986

View more
  11 in total

1.  Comparison studies of chlorazepate administered as a divided daily dose and as a single dose at night.

Authors:  I Dureman; H Malmgren; B Norrman
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

2.  The use of short- and long-acting hypnotics in clinical medicine.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

3.  Physiological and psychological effects of clorazepate in man.

Authors:  M H Lader; S Curry; W J Baker
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

4.  Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics.

Authors:  D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Pharmacokinetics of N-desmethyldiazepam after a single oral dose of clorazepate: the effect of smoking.

Authors:  T R Norman; A Fulton; G D Burrows; K P Maguire
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepam.

Authors:  M Ansseau; A Doumont; R von Frenckell; J Collard
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Intramuscular bioavailability of chlorazepate as compared to diazepam.

Authors:  A Bertler; S Lindgren; J O Magnusson; H Malmgren
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Pharmacokinetics of dipotassium chlorazepate in patients after repeated 50 mg oral doses.

Authors:  A Bertler; S Lindgren; H Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

9.  Efficacy of some benzodiazepines for day-time sleep.

Authors:  A N Nicholson; B M Stone; P A Pascoe
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

10.  Elimination kinetics of desmethyldiazepam in two young and two elderly subjects.

Authors:  G M Pacifici; L Cuoci; G F Placidi; P Fornaro; R Gomeni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.